Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more
Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.
How this was made
The 30-second read
Why it matters
Traders should separate high-conviction fundamentals (EYEP Phase 3 primary endpoint miss) from sentiment catalysts (upgrades/downgrades, coverage initiations) and from policy-driven sector read-through (memory complex).
Market read
The most tradable single-name fundamental shock is EYEP’s Phase 3 failure. LUNR and BABA have concrete, deal-like catalysts, while WDAY and JBLU reflect analyst-driven sentiment shifts. Memory stocks react to a US policy stance on Apple and Chinese memory chips.
What to watch
For LUNR and BABA, the article lacks deal terms and execution timelines; for memory names, the policy quote may not translate into enforceable procurement changes.
Background
This is a midday movers roundup that attributes moves to a mix of clinical trial outcomes, reported corporate transactions, analyst rating changes, an SEC-reported insider purchase, and a US policy quote affecting memory supply-chain expectations.
Ticker impact
Intuitive Machines shares jumped 9% after receiving an authorization to proceed for a $600 million multisatellite communications infrastructure program.
Likely supports continued upside momentum near term, with follow-through dependent on contract execution details.
The article cites a specific $600 million program and a new authorization to proceed, which is more actionable than prior backlog commentary.
JetBlue Airways stock dropped 6% and is on pace for its seventh decline in nine sessions after Seaport Research Partners cut its rating to neutral.
Near-term pressure may persist, though magnitude likely depends on whether other catalysts emerge.
The catalyst is an analyst rating change, which can move price but is less fundamental than earnings, guidance, or a new event.
Onto Innovation shares rose 5% after Goldman Sachs initiated coverage with a buy rating, with the stock up more than 120% this year.
Supports upside bias intraday to short term, but risk of mean reversion exists given the already-large YTD gain.
The article provides a clear catalyst (initiation with buy) but no new fundamentals beyond the rating.
Workday shares fell 4% after Deutsche Bank downgraded WDAY to hold from buy following a 40% surge since July 24.
Near-term downside or consolidation is likely as traders reassess the post-surge narrative.
The catalyst is explicit (downgrade) and tied to a recent outsized move, but the article does not add new company-specific fundamentals.
Alibaba shares rose about 1% after Reuters said it is set to sell its game development business for more than $2 billion to Trustar Capital.
Likely supports a positive re-rating near term, with details of deal structure and proceeds determining follow-through.
The article cites deal size and buyer, but does not provide terms beyond the expected sale value.
Sandisk jumped 10% after U.S. Commerce Secretary Howard Lutnick said the Trump administration opposes Apple buying Chinese memory chips.
Supports continued strength in the memory complex if the policy signal is reinforced.
The catalyst is a political/policy quote and the article provides no direct linkage to Sandisk fundamentals beyond the immediate move.
Western Digital added 5% after Lutnick said the administration opposes Apple buying Chinese memory chips.
Near-term upside bias is possible, but follow-through depends on policy implementation details.
This is a sector reaction to a political statement rather than a company-specific disclosure.
Micron Technology tacked on 6% after Lutnick said the Trump administration opposes Apple buying Chinese memory chips.
Could sustain relative strength if traders continue to price in supply-chain re-routing.
The article does not quantify expected procurement impact for Micron.
Market effects
Policy commentary on Apple sourcing of Chinese memory chips is driving a broad memory complex reaction (SNDK, WDC, MU, STX).
Primarily US-listed equities; sentiment spillover could affect broader semiconductor and aerospace/space-adjacent risk appetite.
US policy stance on China-linked supply chains can influence global memory pricing expectations and procurement strategies.
Counterpoint
Analyst rating changes and insider buys may be partially priced in; the biggest fundamental repricing here is EYEP’s Phase 3 failure, while others may fade without follow-on details.
Key entities
- public_companyEyePoint Pharmaceuticals
Duravyu failed to achieve the primary goal in a Phase 3 trial, triggering a sharp selloff.
- public_companyIntuitive Machines
Received authorization to proceed for a $600 million multisatellite communications infrastructure program.
- public_companyWorkday
Deutsche Bank downgraded to hold from buy after a large post-July surge.
- public_companyAlibaba
Reportedly set to sell its game development business for more than $2 billion.
- public_companyIntel
CEO reported an insider purchase of more than 105,000 shares at $95 each via SEC filing.
